Drug Type Bispecific antibody |
Synonyms anti-TNFα/IL-17A Bispecific antibody - Hanmi Pharmaceutical, BH 1657, BH1657 |
Target |
Mechanism IL-17A inhibitors(Interleukin 17A inhibitors), TNF-α inhibitors(Tumor necrosis factor α inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Rheumatoid Arthritis | Preclinical | KR | - |